DOWNLOAD the newest Itcerttest ACNS PDF dumps from Cloud Storage for free: https://drive.google.com/open?id=1x8icojzj00c3W7WNH-NfhYAp8RRz4P94
Many candidates know our exam bootcamp materials are valid and enough to help them clear Nursing ACNS exams. But they are afraid that purchasing on internet is not safe, money unsafe and information unsafe. In fact you may worry too much. Online sale is very common. Every year there are thousands of candidates choose our ACNS Exam Bootcamp materials and pass exam surely. Money is certainly safe. PayPal will guarantee your money and your benefits safe. We have strict information secret system to guarantee that your information is safe too.
| Section | Weight | Objectives |
|---|---|---|
| APRN Core Competencies | 16% | - Advanced Pathophysiology - Advanced Pharmacology - Advanced Health Assessment |
| Clinical Practice | 46% | - Care Planning and Implementation - Health Promotion and Disease Prevention - Pharmacologic and Nonpharmacologic Management - Health Assessment and Diagnosis - Evaluation of Outcomes |
| Health Care Systems and Policy | 5% | - Healthcare Delivery Models - Resource Management - Regulatory and Policy Frameworks |
| Role and Professional Responsibility | 33% | - Ethics and Legal Aspects - Clinical Leadership and Consultation - Evidence-Based Practice and Research - Quality Improvement and Safety - Education and Mentorship |
>> Practice ACNS Exams Free <<
The world is rapidly moving forward due to the prosperous development of information. Our company is also making progress in every side. The first manifestation is downloading efficiency. A lot of exam candidates these days are facing problems like lacking of time, or lacking of accessible ways to get acquainted with high efficient ACNS guide question like ours. We emphasize on customers satisfaction, which benefits both exam candidates and our company equally. By developing and nurturing superior customers value, our company has been getting and growing more and more customers. To satisfy the goals of exam candidates, we created the high quality and high accuracy ACNS real materials for you. By experts who diligently work to improve our practice materials over ten years, all content are precise and useful and we make necessary alternations at intervals.
NEW QUESTION # 22
In Health Maintenance Organizations and Preferred Provider Organizations, providers are paid a monthly fee for each patient enrolled in their panel. What is this fee called?
Answer: D
Explanation:
The correct term for the monthly fee paid to providers by Health Maintenance Organizations (HMOs) or Preferred Provider Organizations (PPOs) for each patient enrolled in their panel is called a "capitation fee." This system is fundamentally different from other payment methods in healthcare, such as fee-for-service or reimbursement charges.
In a capitation model, the healthcare provider receives a set amount of money per patient per month regardless of how many times the patient visits or the type of medical care required. This payment structure is designed to encourage providers to focus on maintaining the overall health of their patients, as their income is not dependent on the number of services rendered.
Contrary to other options like "enrollment fee," "reimbursement charge," or "premium," which have different implications in healthcare finance, a capitation fee specifically relates to the payment agreement between providers and insurance networks (HMOs or PPOs). An enrollment fee might be a one-time charge when a patient joins a new service, a reimbursement charge often refers to payments made after services are rendered based on specific billing claims, and a premium is generally the amount paid by beneficiaries for health coverage, paid monthly or annually to the insurance provider.
Thus, understanding the term "capitation fee" is crucial for grasping how healthcare providers manage their financial operations and patient care strategies within the frameworks of HMOs and PPOs. This model aims to optimize healthcare outcomes by making the providers less reliant on a fee-for-service system, which can sometimes incentivize unnecessary treatments. Instead, capitation encourages providers to deliver necessary and preventive care efficiently to keep patients healthy under a fixed budget.
NEW QUESTION # 23
What does a nurse consider when applying research utilization?
Answer: B
Explanation:
When a nurse is considering the application of research utilization, there are several critical factors to evaluate to ensure the research is not only applicable but also beneficial in a clinical setting. These include safety, effectiveness, cost, and impact. Let's delve deeper into each of these considerations:
Safety: This is the foremost concern. When a nurse is applying research findings to patient care, the safety of the patient must be the top priority. The research used must have demonstrated that the interventions or procedures considered do not pose undue risk to patients. This involves assessing the methodology of the research to ensure it adheres to ethical standards, and that the findings have been replicated in multiple studies or under various conditions to confirm safety outcomes.
Effectiveness: The nurse must consider whether the research provides clear evidence that the interventions or practices in question actually work and achieve the desired outcomes. This involves looking at the strength and consistency of the evidence. For instance, were the study results statistically significant? Were they clinically significant as well? Effectiveness also involves evaluating whether the research is relevant to the specific patient populations the nurse is working with, as results can vary widely among different groups.
Cost: Healthcare costs are a significant concern for both providers and patients. When applying research, it is important for nurses to consider the financial implications. This includes the direct costs involved in implementing new practices or interventions, such as the need for new equipment or additional training, as well as the potential for cost savings. For example, a more expensive intervention might be justified if it leads to shorter hospital stays or fewer readmissions.
Impact: Lastly, the broader impact of applying the research should be considered. This includes the potential effects on patient satisfaction, quality of life, and overall healthcare outcomes. It also involves considering the impact on the healthcare system itself, such as changes in workflow or the need for additional staffing. Furthermore, nurses should think about the long-term impacts, which might include setting new standards of care or influencing future research directions.
In summary, when a nurse is looking at research utilization, they must critically assess all these factors - safety, effectiveness, cost, and impact - to ensure that the research is not only applicable but will also enhance patient care and optimize healthcare resources. This comprehensive evaluation helps in making informed decisions that align with both clinical goals and ethical standards.
NEW QUESTION # 24
A 52-year old female is in the office with a new-onset of reflux esophagitis. You are assessing her and asking pertinent questions. What do you expect to find with her that would support this diagnosis?
Answer: D
Explanation:
When assessing a 52-year-old female patient presenting with new-onset reflux esophagitis, certain findings in her medical history and symptoms can support the diagnosis. Here are the pertinent factors to consider:
**Recent Initiation of Estrogen-Progestin Hormonal Therapy**: This is a significant factor to explore. Medications can impact the function of the gastrointestinal system, particularly the lower esophageal sphincter (LES). The LES is a critical barrier preventing the backflow of stomach contents, including acid, into the esophagus. Estrogen and progestin, components of many hormonal therapies, are known to potentially decrease LES pressure. This reduction in pressure can lead to or exacerbate gastroesophageal reflux disease (GERD), presenting as reflux esophagitis. Asking about the timing of hormonal therapy initiation and correlating it with the onset of reflux symptoms can provide valuable diagnostic insight.
**Symptoms Consistent with Reflux Esophagitis**: The patient may report classic symptoms such as heartburn, regurgitation of food or sour liquid, and chest pain. Additionally, symptoms like difficulty swallowing (dysphagia), a sensation of a lump in the throat, and chronic cough might also be present. These symptoms often worsen after eating, when lying down, or bending over.
**Lifestyle and Dietary Factors**: Inquiring about recent changes in diet, alcohol consumption, smoking habits, and body weight can be helpful. Increased intake of fatty foods, alcohol, caffeine, and smoking are known risk factors for GERD. Obesity also contributes to increased abdominal pressure, which can promote the reflux of acid into the esophagus.
**Active H. pylori Infection**: While Helicobacter pylori infection is primarily associated with gastritis and peptic ulcer disease, it can indirectly influence the development of reflux esophagitis. The infection can lead to changes in the stomach lining and potentially affect acid production and gastric emptying, which might exacerbate reflux symptoms.
**Exclusion of Other Causes**: It is also crucial to rule out other potential causes of the patient's symptoms. For instance, a report of melena (black, tarry stools) might suggest gastrointestinal bleeding, which requires immediate attention and a different diagnostic pathway. Similarly, symptoms like recent weight loss and fatigue might necessitate a broader investigation to rule out other systemic conditions. By exploring these aspects during the patient interview and examination, a more comprehensive understanding of the potential cause of the reflux esophagitis can be achieved, guiding appropriate management and treatment strategies.
NEW QUESTION # 25
When counseling a patient with allergic rhinitis, you prescribe Cromolyn. The ACNS understands that its mechanism of action is as a/an:
Answer: D
Explanation:
When counseling a patient with allergic rhinitis and considering the use of Cromolyn, it is crucial to understand its mechanism of action and how it fits into the treatment regimen. Cromolyn is classified as a mast cell stabilizer. Here's an expanded explanation of how Cromolyn works and why it is used for allergic rhinitis:
Mast cells are a type of white blood cell that play a significant role in the body's allergic response. During an allergic reaction, allergens trigger the release of histamine and other chemicals from these mast cells, leading to symptoms such as sneezing, itching, and runny nose. Cromolyn works by stabilizing the mast cell membranes, thereby preventing them from releasing these inflammatory mediators when they encounter an allergen. This action helps in reducing the severity of the symptoms associated with allergic reactions.
Unlike some other treatments for allergic rhinitis, such as antihistamines or corticosteroids, Cromolyn does not work immediately after administration. It is not effective at treating acute symptoms. Instead, Cromolyn is used as a preventive measure. Patients typically need to use the Cromolyn nasal spray regularly, starting it before the allergy season begins or before coming into contact with known allergens. It may take about a week or more of consistent usage before significant symptom relief is achieved.
Because of its mechanism of action and its preventive nature, Cromolyn is an excellent choice for patients who have predictable seasonal allergies or who can anticipate exposure to specific allergens. It is particularly useful for those who prefer to use a medication with fewer side effects compared to systemic medications like corticosteroids. Cromolyn is generally well-tolerated, and side effects are rare, making it suitable for long-term use in managing allergic rhinitis.
In summary, when prescribing Cromolyn for allergic rhinitis, it is important to educate patients about its role as a mast cell stabilizer. Patients should understand that they need to begin treatment before their allergy season starts and that consistent daily use is crucial for the medication to be effective. Additionally, they should be informed that Cromolyn is used for the prevention of symptoms rather than for immediate relief. This understanding will help ensure patient compliance and satisfaction with this treatment approach.
NEW QUESTION # 26
After thoroughly assessing your 31-year-old patient, you determine he requires a Tumor Necrosis Factor Inhibitor to treat his musculoskeletal disorder. Which of these would you NOT prescribe?
Answer: C
Explanation:
The question asks which medication among the listed options should not be prescribed if a Tumor Necrosis Factor (TNF) Inhibitor is required for a patient's treatment. To address this question, it is essential to understand the classification and therapeutic use of each listed drug.
Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs are primarily used to treat inflammation, mild to moderate pain, and fever. Importantly, unlike TNF inhibitors, NSAIDs do not specifically target TNF-alpha, a cytokine that plays a key role in the inflammatory process. Therefore, while piroxicam can be useful for symptomatic relief in musculoskeletal disorders, it does not manage the underlying disease mechanisms in conditions where TNF-alpha inhibition is specifically required.
Adalimumab, infliximab, and etanercept, on the other hand, are all TNF inhibitors. These medications are used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory conditions where TNF-alpha plays a significant pathogenic role. By inhibiting TNF-alpha, these drugs help reduce inflammation, thereby managing both symptoms and progression of the disease.
Adalimumab is a monoclonal antibody that binds to TNF-alpha, neutralizing its activity. Infliximab is another monoclonal antibody that works similarly but is administered intravenously. Etanercept is a fusion protein that also inhibits TNF-alpha but is structurally different from the monoclonal antibodies.
Given that the patient needs a TNF inhibitor, the correct choice of medication would be either adalimumab, infliximab, or etanercept, as all these drugs directly target and inhibit the activity of TNF-alpha, addressing the underlying pathophysiology of the disease.
Therefore, piroxicam, being an NSAID and not a TNF inhibitor, would not be appropriate for the specific treatment requirement of inhibiting TNF-alpha. It would not effectively manage the disease at the level required by the patient's condition, making it the correct answer to the question of which drug you would not prescribe.
NEW QUESTION # 27
......
With the rapid development of the world economy, it has been universally accepted that a growing number of people have longed to become the social elite. However, the competition of becoming the social elite is fierce for all people. The ACNS latest dumps will be a shortcut for a lot of people who desire to be the social elite. If you try your best to prepare for the ACNS Exam and get the related certification in a short time, it will be easier for you to receive the attention from many leaders of the big company, and it also will be very easy for many people to get a decent job in the labor market by the ACNS learning guide.
ACNS Guaranteed Questions Answers: https://www.itcerttest.com/ACNS_braindumps.html
P.S. Free 2026 Nursing ACNS dumps are available on Google Drive shared by Itcerttest: https://drive.google.com/open?id=1x8icojzj00c3W7WNH-NfhYAp8RRz4P94